Skip to main content

Is Science Comedian an Oxymoron? No, it's Tim Lee, Ph.D., and He's Definitely No Moron!

A sow and a soybean walk into a lab.

It might be the start of a good joke. I don’t know. But Tim Xtreme Lee has done the due diligence to extract the funny from the corn.  

World-Leading Seqirus Flu Vax Factory in NC Makes History -- Again

The billion-dollar cell culture Seqirus vaccine factory in Holly Springs has hit yet another milestone. The highly skilled workers at the sprawling factory southeast of Raleigh successfully produced the world’s first cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.

CiVentiChem Gets First FDA Nod on Commercial API from Cary HQ

CiVentiChem has received its first U.S. Food and Drug Administration approval for a generic commercial active pharmaceutical ingredient (API) manufactured at its Cary headquarters.

Precision Nutrition Needed for Healthy Military Muscles

Eat colorful meals and make sure you get enough choline. That’s the key advice two nutrition experts offered during lunch at the Medical, BioMedical & BioDefense: Support the Warfighter symposium in Chapel Hill last week.

NCBiotech Goes to BIO 2017

This post will be updated with news, stories and observations from the Biotechnology Innovation Organization's 2017 conference in San Diego, June 19-22.

Tags: 

Humacyte Tabbed as ‘Technology Pioneer’ by World Economic Forum

Humacyte, a Morrisville-based regenerative medicine company, has been selected as one of the World Economic Forum’s 30 “Technology Pioneers” for 2017.

US Military Special Operations Forces Have Special Needs

The U.S. Special Operations Forces, which include Navy Seals, Army Rangers, and Air Force Special Tactics, have 9,500 people deployed in 90 countries. So they have special needs when it comes to acquisitions from private-sector partners.

Achelios Gets FDA Guidance on Approval Path for Migraine Drug

Achelios Therapeutics of Chapel Hill has completed a meeting with the U.S. Food and Drug Administration about a path to approval for its leading drug candidate, TOPOFEN, to treat acute and chronic migraine, a condition known for its debilitating pain.

Event Promotes NC Business, US Military Partnerships

One thing was clear, from the opening keynote to the final session, after a unique gathering of North Carolina business and Pentagon procurement leaders: the military is actively seeking private-sector partners to support the health and healing of U.S. warfighters and their families.

CivaTech’s Radiation Device Tested in First Pancreatic Cancer Patient

A Virginia man has become the first person in the world to be treated for pancreatic cancer with a bio-absorbable, implantable radiation device called CivaSheet, developed by Durham-based CivaTech Oncology.

 

Pages

Subscribe to RSS - NCBiotech